These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 19796352

  • 1. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.
    Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, Higenbottam J, Khaykin Y.
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):320-9. PubMed ID: 19796352
    [Abstract] [Full Text] [Related]

  • 2. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.
    Pacing Clin Electrophysiol; 2010 Jun 01; 33(6):696-704. PubMed ID: 20059719
    [Abstract] [Full Text] [Related]

  • 3. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Jun 01; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 4. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.
    Rev Esp Cardiol; 2006 Jun 01; 59(6):537-44. PubMed ID: 16790196
    [Abstract] [Full Text] [Related]

  • 5. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.
    J Am Coll Cardiol; 2011 Sep 27; 58(14):1485-96. PubMed ID: 21939834
    [Abstract] [Full Text] [Related]

  • 6. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB, Cheng KA, Gao P, Cheng ZW, Fan JB, Jiang XC, Fang Q.
    Chin Med J (Engl); 2010 Apr 05; 123(7):848-51. PubMed ID: 20497676
    [Abstract] [Full Text] [Related]

  • 7. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Apr 05; 70(11):1099-110. PubMed ID: 23180517
    [Abstract] [Full Text] [Related]

  • 8. Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience.
    Verma A, Wulffhart Z, Lakkireddy D, Khaykin Y, Kaplan A, Sarak B, Biria M, Pillarisetti J, Bhat P, Di Biase L, Constantini O, Quan K, Natale A.
    Heart; 2010 Apr 05; 96(7):510-5. PubMed ID: 19884110
    [Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):883-9. PubMed ID: 20132378
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value and temporal behavior of the planar QRS-T angle in patients with nonischemic cardiomyopathy.
    Pavri BB, Hillis MB, Subacius H, Brumberg GE, Schaechter A, Levine JH, Kadish A, Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Circulation; 2008 Jun 24; 117(25):3181-6. PubMed ID: 18574059
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB, Della Rocca DG, Papavasileiou LP, Panattoni G, Sergi D, Duro L, Mahfouz K, Magliano G, Santini L, Romeo F.
    J Cardiovasc Med (Hagerstown); 2011 Nov 24; 12(11):779-84. PubMed ID: 21941203
    [Abstract] [Full Text] [Related]

  • 12. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.
    Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108
    [Abstract] [Full Text] [Related]

  • 13. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Circulation; 2006 Feb 14; 113(6):776-82. PubMed ID: 16461817
    [Abstract] [Full Text] [Related]

  • 14. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
    LaPointe NM, Stafford JA, Pappas PA, Al-Khatib SM, Anstrom KJ.
    Ann Pharmacother; 2009 Jul 14; 43(7):1189-96. PubMed ID: 19567655
    [Abstract] [Full Text] [Related]

  • 15. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A, Małecka L, Pytkowski M, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Ruzyłło W, Szwed H.
    Kardiol Pol; 2005 Oct 14; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [Abstract] [Full Text] [Related]

  • 16. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.
    Am J Cardiol; 2010 Jan 01; 105(1):105-11. PubMed ID: 20102900
    [Abstract] [Full Text] [Related]

  • 17. Does the abnormal signal-averaged electrocardiogram predict future appropriate therapy in patients with implantable cardioverter-defibrillators?
    Haghjoo M, Arya A, Parsaie M, Dehghani MR, Sadr-Ameli MA.
    J Electrocardiol; 2006 Apr 01; 39(2):150-5. PubMed ID: 16580410
    [Abstract] [Full Text] [Related]

  • 18. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ.
    Circ Cardiovasc Imaging; 2009 May 01; 2(3):183-90. PubMed ID: 19808591
    [Abstract] [Full Text] [Related]

  • 19. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
    Heersche JH, Blom NA, van de Heuvel F, Blank C, Reimer AG, Clur SA, Witsenburg M, ten Harkel AD.
    Pacing Clin Electrophysiol; 2010 Feb 01; 33(2):179-85. PubMed ID: 20025697
    [Abstract] [Full Text] [Related]

  • 20. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies.
    Verma A, Kilicaslan F, Martin DO, Minor S, Starling R, Marrouche NF, Almahammed S, Wazni OM, Duggal S, Zuzek R, Yamaji H, Cummings J, Chung MK, Tchou PJ, Natale A.
    Heart; 2006 Feb 01; 92(2):190-5. PubMed ID: 15923278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.